Vacino Biotech Company Profile, Contacts & Intelligence

Vacino Biotech Overview

Vacino Biotech company was founded in July, 2020 focusing on the product development of vaccine and nucleic acid drug. In 2021, Vacino Biotech was admitted to build up the research center in National Biotechnology Research Park. The universal flu vaccine development project is the first project of Vacino Biotech. Based on Vacino's novel Antigen Discovery technology, a universal COVID vaccine is being developed and scheduled release in 2023. An another project is the development of miRNA nucleic acid drug for treating the Alzheimer's disease. With the advanced nucleic acid modification technology R-MOD, the stability and efficacy of RNA drug is largely improved. An accompanying precision diagnostic is also developed based on the quantitation of miRNA for monitoring the Alzheimer's disease progression.

Headquarters

室 Taiwan, Tw

Website

vacinobiotech.com

Industry

Biotechnology Research

Founded

2020

NAICS

Research and Development in Biotechnology (except Nanobiotechnology)

Vacino Biotech Contact Intelligence

See which contact channels and departments are represented in the visible AeroLeads data.

Vacino Biotech People & Org Chart Preview

Sample people records show job titles and whether email or phone data is available without exposing raw contact details.

Compare Similar Companies to Vacino Biotech

Explore companies in related markets and compare their industry and employee estimates.